Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 AUD | 0.00% | -6.25% | -15.49% |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-15.49% | 11.47M | |
-3.79% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.69% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+4.94% | 8.73B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm : Secures European Patent Allowance for First Pipeline Drug Candidate